Phoenix Life Sciences International Ltd (fka PLSI)

[king koopa]

$MJMD STOCK - WHY ALL THE $$$ FLOW, ALL OF A SUDDEN???

..... This is the question on everyone's mind after this stock hit their volume/price scanners on Friday, and of course, the IHUB breakout board. Are Cannabis stocks finally heating up? Most know that a year ago a company like MJMD would have seen its stock move from .001s to $0.40 + with this share structure and business. This year, so far, things are a bit more down to earth. Here are some points to consider, as possible reasons behind the move:

1. The move on 3/27 was NOT a paid pump and dump promotion... ref. www.pumpsanddumps.com . Because of this, the move and record volume for the stock are hinting at something much bigger.

2. speculation about MJMD's relationship with CannaVest Corp (OTC: CANV), MJMD's raw materials supplier, for a possible merger or buyout...

3. expanded relationship, or combination/merger with strategic partner Phoenix BioPharmaceuticals:

On January 5, 2015, the Company entered into an additional license agreement with Phoenix Bio Pharmaceuticals Corporation to expand the territories covered under its original license agreement dated March 14, 2014. Under the terms of the additional license agreement, the Company acquired the marketing rights to distribute products developed by Phoenix Bio Pharmaceuticals Corporation in Australia and New Zealand for ten years. In exchange for the license, the Company has issued 250,000,000 restricted common shares at $0.016 per common share, for an aggregate value of $4,000,000.

This also explains the low float here with a 360M OS as of March 9, 2015, 250M as shown here is restricted. (From the 10Q/A The number of outstanding shares of the registrant's common stock on March 9, 2015: 361,322,812)

4. Possibility that a huge purchase order will be announced for MJMD's medical marijuana products:

"To date, 23 states, along with the District of Columbia, have legalized medical marijuana and 12 others have legalized the limited use of low-THC marijuana for medical purposes."

5. Knowledge of how BIG their new product(s) may become:

New Product Development Agreement : On October 23, 2014, the Company entered into a New Product Development Agreement (the “NPD Agreement”) with Phoenix Pharms for use of Phoenix Pharms’ expertise in identifying new product business development opportunities related to expanding the Company’s product offerings. The NPD Agreement is for a period of four months at $16,000 per month. As of November 30, 2014, the Company had paid $64,000 towards the NPD Agreement and has no further obligations under the NPD Agreement.

6. Sales only just began in October 2014. Perhaps numbers now are looking very good as they expand their retail presence:

Longmont, CO / ACCESSWIRE / September 16, 2014 / MediJane Holdings Inc. (MJMD) ("MediJane") a medical cannabis company focused on the wholesale sales and distribution of smokeless medical cannabis products, is pleased to announce MediStrips are now available for sale at in dispensaries' around Sacramento, CA.

7. Based on the 360M OS and 250M restricted, the max float at 110M shares, clean balance sheet, solid asset base, first full quarter of revenues has not even been reported yet, products fully developed and expanding, this Cannabis gem is hitting everyone's radars and investors know the potential here..... $$$$$$$$$$ MJMD

References: http://finance.yahoo.com/news/medijane-holdings-begins-california-retail-200500266.html

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10550048